As of 2026-03-30, the Fair Value of Knight Therapeutics Inc (GUD.TO) is -0.27 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 7.20 CAD, the upside of Knight Therapeutics Inc is -103.81%.
With the market price of 7.20 CAD and our fair value calculation, Knight Therapeutics Inc (GUD.TO) is not a good investment. Investing in GUD.TO stocks now will result in a potential loss of 103.81%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | 15.68 | -29.89 | -16.83 | 4.33 | -5.37 | -6.42 |
| YoY growth | -62.77% | -290.70% | 43.68% | 125.73% | -224.05% | -81.62% |
| Market Cap (mil) | 705.82 |
| P/E | |
| Forward P/E | 168.05x |
| EPS | -0.05 |
| Avg earnings growth rate | -81.62% |
| TTM earnings | -5.37 |